Organisation of Pharmaceutical Producers of India


46th AGM of OPPI at Taj Mahal Mumbai


L to R- Mr Tapan Ray, Mr. Sam Pitroda, Shri Dilsher Singh Kalha, Mr Ranjit Sahani, Shri Chandra Prakash Singh

Mumbai, 15 September 2012:The 46th Annual General Meeting of the Organisation of Pharmaceutical Producers of India (OPPI) was held today at The Taj Mahal Palace, Mumbai. The meeting was presided over by MrRanjit Shahani, President, OPPI and Vice-Chairman & Managing Director, Novartis India Ltd.

On the occasion, the 46th Annual Report was released, outlining the various initiatives undertaken by OPPI and highlights of the major events in 2011-2012. The Report elucidates the pharmaceutical industry’s concerns and challenges in general as well as those of member companies by analyzing implications of various issues related to the pharmaceutical industry.

Placing Universal Healthcare (UHC) at the top of the agenda, OPPI's focus this year will be on ‘Improving Access to Health’ and enabling an environment that fosters research and innovation in the country.

Expressing concern over the recent policy decision on FDI and pricing, OPPI Director General Tapan Ray said: “OPPI will continue to work in tandem with the government and other stakeholders to uphold high standards of governance in all areasthat impact health and patients’ interest, including issues related to access to medicines, investments in the pharmaceutical sector, clinical trials, regulatory compliances and ethical promotion of medicines, just to name a few. OPPI member companies will continue to act responsibly and in close collaboration with all stakeholders towards achieving the common goal of ‘health for all’ as envisioned in Vision 2020.”

 OPPI also presented Excellence Awards to top scientists working in drug discovery and pharmacology, apart from releasing their various publications.

Speaking on the prospects of the pharmaceutical industry, Mr Ranjit Shahani said: “Sustaining the growth of the pharmaceuticalindustry in the long term is a challenge due to various uncertainties prevailing in the country. Further, the absence of an ecosystem that fosters innovation will be to the long term detriment of the patient if not addressed speedily.” 

Among the key dignitaries present on the occasion were Shri Chandra Prakash Singh, Chairman, National Pharmaceutical Pricing Authority, Government of India, Shri Dilsher Singh Kalha, Secretary, Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India and Mr Sam Pitroda,Advisor to the Prime Minister of India, Public Information, Infrastructure & Innovations as the Guest of Honour.

The AGM saw stalwarts from the Government, Regulatory Authorities, overseas/local opinion leaders, Heads of Companies, Senior Managers of the Pharmaceutical Industry and other dignitaries come together and discuss key issues. More than 200 delegates participated in the OPPI AGM.
 
Organisation of Pharmaceutical Producers of India (OPPI) established in 1965 is a premier association of research and innovation driven pharmaceutical companies in Indiaand is also a scientific and professional body. It caters to the needs of Research based Pharmaceutical Industry thereby creating and sustaining an environment conducive to innovation and growth, simultaneously, facilitating industry and stakeholders partnership through various advisory and consultative processes to achieve the Healthcare objectives of the Nation.For more information, please visit : www.indiaoppi.com

Comments

Popular posts from this blog

सभी माओं को सुष्मिता सेन का संदेश: अब 'हाँ' अधिक बार कहिये

World’s 1st Tech-Enabled Courier Papers N Parcels Launched by 13-year-old Tilak Mehta

''Sepia'' to be screened at MAMI